Skip to content

The Effect of Dexmedetomidine Infusion on Post-operative Cognitive Function and Oxidative Stress in Cardiac Surgery

The Effect of Dexmedetomidine Infusion on Post-operative Cognitive Function and Oxidative Stress in Patients Undergo Cardiopulmonary Bypass Machine Facilitated Elective Cardiac Surgery

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03054857
Enrollment
100
Registered
2017-02-16
Start date
2015-06-30
Completion date
2016-12-31
Last updated
2018-06-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cognition Disorders, Oxidative Stress

Brief summary

Objective: The aim of this study was to determine the effect of dexmedetomidine in reducing postoperative cognitive dysfunction (POCD) in cardiac surgical patients which use cardiopulmonary bypass machine (CPB). Materials and Methods: This study was double-blinded, randomized controlled trial. Patients scheduled for elective CPB facilitated cardiac surgery were randomly assigned in two groups, dexmedetomidine group (DEX) or control group. The cognitive tests (MoCA test and Short bless test) were done before the operation, 48 hours, and 7 days postoperatively. POCD was defined as a decline of 1SD of baseline score in any test. Arterial blood sample were analyzed for IL-6, IL-10, TNF-alpha and hs-CRP before induction (T0), after separation from CPB (T1), arrival at ICU (T2) and 24-hour after surgery (T3). Primary outcome was the incidence of POCD and the secondary outcomes were inflammatory response, other postoperative complications, ICU and hospital stay.

Detailed description

After the patients were enrolled in the study, they were allocated into Dexmedetomidine group or control group by computer-based randomization. Patients, surgeons, anesthesiologists and researchers who performed the cognitive test were all blinded to the study groups. General anesthesia was induced with intravenously midazolam 0.1-0.2 mg/kg and fentanyl 5-10 mcg/kg or Thiopental 3-5 mg/kg or Propofol 2 mg/kg. Patients were intubated with pancuronium 1 mg/kg or rocuronium 0.6-1 mg/kg. Anesthesia was maintained with nitrous oxide in oxygen, isoflurane, fentanyl, and pancuronium or rocuronium as required. Standard monitoring was provided including an indwelling radial artery catheter and central venous catheter. Bispectral index (BIS) monitoring was applied and maintained between 40-60 through the operation. Cerebral oximetry was monitored both sides of the brain by non-invasive oximeters at forehead area and the data were recorded. After skin incision, the Dexmedetomidine group received a loading dose of 0.5 mcg/kg of Dexmedetomidine in 20 minutes followed by a continuous IV infusion at 0.4 mcg/kg/hr until the end of operation.The control group received a loading dose and continuous IV infusion of normal saline at the same rate. During the cardiopulmonary bypass, mean arterial pressure was maintained at 60-80 mmHg or 20% from baseline. If hypertension was detected, Nicardipine 0.2 mg was given intravenously. Ephedrine 6 mg or norepinephrine 4 mcg were given within 5 minutes and repeated every 5 minutes if hypotension was presented. Atropine 0.6 mg was administered for bradycardia (heart rate less than 50 beats per minute). After the operation, patients were transferred to Cardio-thoracic intensive care unit and received standard postoperative cardiac surgery care. 2 neuropsychological tests were used to evaluate patients' cognitive function; Montreal Cognitive Assessment (MoCA) and Short blessed test (SBT). These tests were chosen by King Chulalongkorn Memorial Hospital's psychiatrist based on previous studies and the statement consensus on assessment of neurobehavioral outcomes after cardiac surgery published in 1995. All patients were evaluated their cognitive function for 3 points of time, 1st time was at preoperative period (T1), 2nd time was at 48 hours postoperatively (T2) and the last one was at 7 days postoperatively or the day at discharge from the hospital (T3). POCD was defined as a decline of 1 standard deviation (1SD) of baseline score in any test. Blood samples were taken through the radial artery catheter, and sampling times were chosen as follows: before the induction of anaesthesia (T0); after separated from CPB (T1); arrival at intensive care unit (ICU) (T2); 24 hr after surgery (T3). Plasma Tissue Necrotic Factor-Alpha (TNF-α), Interleukin-6 (IL-6) and Interleukin-10 (IL-10) levels were measured by Magnetic Luminex Performance Assay. High sensitivity C-reactive protein (CRP) level were also measured by nephelometry.

Interventions

DRUGDexmedetomidine

After skin incision, the dexmedetomidine group received a loading dose of 0.5 mcg/kg of Dexmedetomidine in 20 minutes followed by a continuous IV infusion at 0.4 mcg/kg/hr until the end of operation.

DRUGPlacebo

The control group received a loading dose and continuous IV infusion of normal saline at the same volume and rate as in the dexmedetomidine group

Sponsors

Chulalongkorn University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* American Society of Anesthesiologists (ASA) physical status I-III.

Exclusion criteria

* patients who were allergy to medication in the research regimen * preoperative left ventricular ejection fraction less than 30% * body mass index more than 35 kg/m2 * preoperative mean arterial pressure less than 60 mmHg * preoperative heart rate less than 45/min * patients with impaired renal function (serum creatinine more than 1.5 mg/dl in female and 2 mg/dl in male) * active liver disease, and who had history of symptomatic cerebrovascular disease * psychiatric problem and other neurological diseases * patients who cannot read

Design outcomes

Primary

MeasureTime frameDescription
Numbers of Participants With Postoperative Cognitive Dysfunction (POCD)48 hoursPOCD was defined as a decline of 1 standard-deviation (1SD) of baseline score in either MoCA test or short bless test.
Number of Participants With Postoperative Cognitive Dysfunction (POCD)7 daysPOCD was defined as a decline of 1SD of baseline score in either MoCA test or short bless test.

Secondary

MeasureTime frameDescription
Number of Participants With Postoperative Complications7 daysNeurological complication, Delirium, dysrhythmia, death
Hospital Stay in Days30 days
ICU Stay in Hours7 days

Participant flow

Participants by arm

ArmCount
Dex Group
After skin incision, the Dexmedetomidine group received a loading dose of 0.5 mcg/kg of Dexmedetomidine in 20 minutes followed by a continuous IV infusion at 0.4 mcg/kg/hr until the end of operation.
49
Placebo Group
The control group received a loading dose and continuous IV infusion of normal saline at the same rate.
50
Total99

Baseline characteristics

CharacteristicPlacebo GroupDex GroupTotal
Age, Continuous52.72 years
STANDARD_DEVIATION 10.975
51.43 years
STANDARD_DEVIATION 13.077
52.08 years
STANDARD_DEVIATION 12.017
Aortic Cross-clamp Time99.88 minutes
STANDARD_DEVIATION 38.38
92.69 minutes
STANDARD_DEVIATION 34.03
96.32 minutes
STANDARD_DEVIATION 36.287
Atrial fibrillation13 Participants12 Participants25 Participants
Baseline Montreal Cognitive Assessment scores (0-30 points)22.88 points
STANDARD_DEVIATION 3.707
22.84 points
STANDARD_DEVIATION 4.464
22.86 points
STANDARD_DEVIATION 4.078
Baseline Short Blessed Test score (0-28 points)5.30 points
STANDARD_DEVIATION 5.754
4.98 points
STANDARD_DEVIATION 4.922
5.14 points
STANDARD_DEVIATION 5.334
BMI26.19 Kilograms per metre square
STANDARD_DEVIATION 19.21
23.08 Kilograms per metre square
STANDARD_DEVIATION 3.09
24.65 Kilograms per metre square
STANDARD_DEVIATION 13.8424
Cardiopulmonary Bypass Time132.34 minutes
STANDARD_DEVIATION 46.55
120.59 minutes
STANDARD_DEVIATION 41.52
126.53 minutes
STANDARD_DEVIATION 44.299
Diabetes Mellitus10 Participants6 Participants16 Participants
Hypertension28 Participants22 Participants50 Participants
Left Ventricular Ejection Fraction63.27 percentage of left ventricular ejection
STANDARD_DEVIATION 11.55
62.26 percentage of left ventricular ejection
STANDARD_DEVIATION 11.53
62.7717 percentage of left ventricular ejection
STANDARD_DEVIATION 11.48959
Operation type
CABG
18 Participants13 Participants31 Participants
Operation type
CABG with valve surgery
1 Participants5 Participants6 Participants
Operation type
Multiple valve surgery
12 Participants6 Participants18 Participants
Operation type
Single valve surgery
19 Participants25 Participants44 Participants
Operative Time309.28 minutes
STANDARD_DEVIATION 79.97
301.73 minutes
STANDARD_DEVIATION 87.7
305.55 minutes
STANDARD_DEVIATION 83.541
Region of Enrollment
Thailand
50 Participants49 Participants99 Participants
Serum Creatinine0.95 miligram per decilitre
STANDARD_DEVIATION 0.27
0.94 miligram per decilitre
STANDARD_DEVIATION 0.24
0.9445 miligram per decilitre
STANDARD_DEVIATION 0.25329
Sex: Female, Male
Female
18 Participants23 Participants41 Participants
Sex: Female, Male
Male
32 Participants26 Participants58 Participants
Weight62.69 kilograms
STANDARD_DEVIATION 11.81
60.88 kilograms
STANDARD_DEVIATION 12.5
61.794 kilograms
STANDARD_DEVIATION 12.128

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 490 / 50
other
Total, other adverse events
13 / 4911 / 50
serious
Total, serious adverse events
0 / 491 / 50

Outcome results

Primary

Number of Participants With Postoperative Cognitive Dysfunction (POCD)

POCD was defined as a decline of 1SD of baseline score in either MoCA test or short bless test.

Time frame: 7 days

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Dex GroupNumber of Participants With Postoperative Cognitive Dysfunction (POCD)7 Participants
Placebo GroupNumber of Participants With Postoperative Cognitive Dysfunction (POCD)6 Participants
p-value: 0.63695% CI: [0.409, 4.319]Chi-squared
Primary

Numbers of Participants With Postoperative Cognitive Dysfunction (POCD)

POCD was defined as a decline of 1 standard-deviation (1SD) of baseline score in either MoCA test or short bless test.

Time frame: 48 hours

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Dex GroupNumbers of Participants With Postoperative Cognitive Dysfunction (POCD)12 Participants
Placebo GroupNumbers of Participants With Postoperative Cognitive Dysfunction (POCD)8 Participants
p-value: 0.28995% CI: [0.689, 3.406]Chi-squared
Secondary

Hospital Stay in Days

Time frame: 30 days

ArmMeasureValue (MEAN)Dispersion
Dex GroupHospital Stay in Days9.367 daysStandard Deviation 3.604
Placebo GroupHospital Stay in Days10.42 daysStandard Deviation 4.248
p-value: 0.18795% CI: [-2.626, 0.52]t-test, 2 sided
Secondary

ICU Stay in Hours

Time frame: 7 days

ArmMeasureValue (MEAN)Dispersion
Dex GroupICU Stay in Hours33.79 hoursStandard Deviation 36.43
Placebo GroupICU Stay in Hours38.44 hoursStandard Deviation 39.17
p-value: 0.54395% CI: [-19.74, 10.45]t-test, 2 sided
Secondary

Number of Participants With Postoperative Complications

Neurological complication, Delirium, dysrhythmia, death

Time frame: 7 days

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Dex GroupNumber of Participants With Postoperative ComplicationsPostoperative delirium0 Participants
Dex GroupNumber of Participants With Postoperative ComplicationsEmbolic Stroke0 Participants
Placebo GroupNumber of Participants With Postoperative ComplicationsPostoperative delirium1 Participants
Placebo GroupNumber of Participants With Postoperative ComplicationsEmbolic Stroke1 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026